Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Kim

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Nanomedicine (London, England)|January 21, 2015
A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapyDipanjan Pan, Benjamin Kim, Grace Hu, et al.
JACC. Basic to Translational Science|August 1, 2018
Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet ActivityEmanuela Marcantoni, Nicole Allen, Matthew R Cambria, et al.
Nanomedicine (London, England)|June 20, 2012
Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrugDipanjan Pan, Nibedita Sanyal, Anne H Schmieder, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 11, 2021
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia AK John Pasi, Michael Laffan, Savita Rangarajan, et al.
Journal of Palliative Medicine|July 18, 2015
Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced CancerSangeeta C Ahluwalia, Diana M Tisnado, Anne M Walling, et al.
Gene Therapy|August 23, 2021
Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transferKrystal Sandza, Annie Clark, Elli Koziol, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2002
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)David S Howland, Jian Liu, Yijin She, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2024
A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiativeElizabeth Clearfield, Benjamin Kim, Sarah Ford, et al.
Journal of Gastroenterology and Hepatology|August 30, 2007
Visceral obesity as a risk factor for colorectal neoplasmTae-Hoon Oh, Jeong-Sik Byeon, Seung-Jae Myung, et al.
Blood|September 11, 2020
Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapySteffen Rosen, Stefan Tiefenbacher, Mary Robinson, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Nanomedicine (London, England)|January 21, 2015
A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapyDipanjan Pan, Benjamin Kim, Grace Hu, et al.
JACC. Basic to Translational Science|August 1, 2018
Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet ActivityEmanuela Marcantoni, Nicole Allen, Matthew R Cambria, et al.
Nanomedicine (London, England)|June 20, 2012
Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrugDipanjan Pan, Nibedita Sanyal, Anne H Schmieder, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 11, 2021
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia AK John Pasi, Michael Laffan, Savita Rangarajan, et al.
Journal of Palliative Medicine|July 18, 2015
Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced CancerSangeeta C Ahluwalia, Diana M Tisnado, Anne M Walling, et al.
Gene Therapy|August 23, 2021
Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transferKrystal Sandza, Annie Clark, Elli Koziol, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2002
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)David S Howland, Jian Liu, Yijin She, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2024
A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiativeElizabeth Clearfield, Benjamin Kim, Sarah Ford, et al.
Journal of Gastroenterology and Hepatology|August 30, 2007
Visceral obesity as a risk factor for colorectal neoplasmTae-Hoon Oh, Jeong-Sik Byeon, Seung-Jae Myung, et al.
Blood|September 11, 2020
Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapySteffen Rosen, Stefan Tiefenbacher, Mary Robinson, et al.
Pageof 9